Raymond James Financial’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-34,787
Closed -$242K 5170
2025
Q3
$242K Buy
34,787
+8,228
+31% +$58K ﹤0.01% 4522
2025
Q2
$157K Buy
26,559
+1,687
+7% +$9.71K ﹤0.01% 4638
2025
Q1
$159K Sell
24,872
-219,982
-90% -$2.12M ﹤0.01% 4474
2024
Q4
$2.91M Buy
+244,854
New +$4.17M ﹤0.01% 2695

Other funds holding ASPN

Raymond James Financial's ASPN Position: Q4 2025 in Review

Raymond James Financial sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 34,787 shares — an estimated $242K sold.

Raymond James Financial first reported a position in ASPN in Q4 2024 and held it in 4 quarters. The position peaked at $2.91M in Q4 2024. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Raymond James Financial reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Raymond James Financial sold 34,787 Aspen Aerogels shares in Q4 2025, an estimated $242K.
  • Raymond James Financial first reported a position in Aspen Aerogels in Q4 2024 and held it in 4 quarters.
  • Raymond James Financial's Aspen Aerogels position peaked at $2.91M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.